Literature DB >> 16471211

[A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old].

Xiao-feng Liang1, Yuan-sheng Chen, Xiao-jun Wang, Xiong He, Li-juan Chen, Jun Wang, Chang-ying Lin, Hu-qun Bai, Jun Yan, Gang Cui, Jing-jin Yu.   

Abstract

OBJECTIVE: To better understand and measure the impact from immunization activities over the last 10-years, we conducted a sero-epidemiological study using the remaining blood samples of a nationwide survey on Nutrition and Health in Chinese residents, in 2002.
METHODS: HBsAg, anti-HBs and anti-HBc in blood samples were tested using enzyme-linked immunosorbent assay(ELISA) reagents and revised by solid phase radioimmunoassay and Abbott ELISA reagents.
RESULTS: Among population older than 3 years, the prevalence rates of HBsAg, anti-HBs and hepatitis B virus(HBV) infection were 9.09%, 37.48% and 50.04% but for children between 3 and 12 year olds, they were 5.03%, 45.33% and 29.10% respectively. Among population older than 3 years, the rates of HBsAg and HBV infection in urban area were 4.61% and 43.51%, but the rates in rural area were 9.41% and 56.77% respectively while for children from 3-years to 12-years old, they rates were 2.10%, 20.45% in urban area and 8.25%, 39.22% in rural areas, respectively.
CONCLUSION: Results revealed that since the hepatitis B vaccine was introduced into the expanded program on immunization(EPI) from 1992, the prevalence rates of HBsAg and HBV infection, especially in the children from 3 to 12 years of age, had obviously declined, suggesting that some changes had happened in the epidemic characters of hepatitis B in China.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16471211

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  22 in total

1.  Association between microRNA polymorphisms and humoral immunity to hepatitis B vaccine.

Authors:  Yongzhen Xiong; Shengli Chen; Ruhong Chen; Weiyan Lin; Jindong Ni
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

Review 2.  Individualized management of pregnant women with high hepatitis B virus DNA levels.

Authors:  Zhao Zhang; Chao Chen; Zhe Li; Ying-Hua Wu; Xiao-Min Xiao
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

3.  Anti-TNF therapy in patients with HBV infection--analysis of 87 patients with inflammatory arthritis.

Authors:  Hua Ye; Xue-wu Zhang; Rong Mu; Lin-kai Fang; Jie-ruo Gu; Jin Lin; Jin-feng Du; Jin-wei Chen; Yi-jia Chen; Li-jun Wu; Xue-feng Pang; Zhan-guo Li
Journal:  Clin Rheumatol       Date:  2014-01       Impact factor: 2.980

4.  A community-based sero-epidemiological study of hepatitis B infection in Lianyungang, China, 2010.

Authors:  Zhang Ting-Lu; Xiao Zhi-Ping; Ling Hong-Yu; Ge Chang-Hong; Ying Liang; Ding Qiang; Xu Kai-Ling; Mao Yan-Ming; Du Yue-He; Zhu Ling-Yang
Journal:  Western Pac Surveill Response J       Date:  2012-08-03

5.  Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China.

Authors:  David W Hutton; Samuel K So; Margaret L Brandeau
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

6.  Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications.

Authors:  Manju Rani; Baoping Yang; Richard Nesbit
Journal:  Bull World Health Organ       Date:  2009-09       Impact factor: 9.408

7.  Establishment of an enzyme-linked immunosorbent assay system for determining soluble CD96 and its application in the measurement of sCD96 in patients with viral hepatitis B and hepatic cirrhosis.

Authors:  J Gong; C Zhu; R Zhuang; C Song; Q Li; Z Xu; Y Wei; K Yang; A Yang; L Chen; B Jin
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

8.  Chronic HBV carrier's acceptance of regular surveilling program in China.

Authors:  Qing Fang; You-Hua Hao; Lei Li; Zhen-Hua Zhang; Jun-Zhong Wang; Ming-Fa Chen; Jian Kang; Dong-Liang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-04-17

9.  Dose-response association between hepatitis B surface antigen levels and liver cancer risk in Chinese men and women.

Authors:  Yang Yang; Jing Gao; Hong-Lan Li; Wei Zheng; Gong Yang; Wei Zhang; Xiao Ma; Yu-Ting Tan; Nathaniel Rothman; Yu-Tang Gao; Wong-Ho Chow; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Int J Cancer       Date:  2016-03-30       Impact factor: 7.396

10.  Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.

Authors:  Jie Shao; Lai Wei; Hao Wang; Yan Sun; Lan-Fang Zhang; Jing Li; Jian-Qiang Dong
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.